CPA/EE, cyproterone acetate/ethinylestradiol
Retatrutide: The Triple Agonist The newest GLP-1 medication in development, retatrutide , is showing jaw-dropping results in clinical trials
These medications work by directly activating the GLP-1 receptor, amplifying the hormones effects
While dietary interventions emphasizing protein, fiber, and whole foods can improve metabolic parameters and support weight management, the effects are generally more modesttypically 3-5% weight loss and HbA1c reductions of 0.5-1.0% when implemented without other interventions, as seen in programs like the Diabetes Prevention Program
Borner T, Geisler CE, Fortin SM, et al
While Semaglutide GLP-1 is not identical to GLP-1, its similarities deliver similar benefits